Dr Kola Tytler MBBS CertHE MBA MSt MRCGPClinical Lead • iatroX
Refer to an asthma/respiratory specialist for the following indications: NICE CKS
- Diagnostic uncertainty in adults or children, including when objective testing has not confirmed asthma but clinical suspicion persists, for consideration of bronchial challenge testing NICE CKS.
- Persistent symptoms and/or exacerbations despite good adherence to optimised ICS-containing treatment for 3–6 months, or severe or difficult-to-treat asthma NICE CKS.
- Suspected occupational asthma: refer to an occupational lung disease service or asthma specialist, ideally for assessment within 6 weeks NICE CKS.
- Previous near-fatal asthma: specialist supervision should continue indefinitely NICE CKS.
- A severe exacerbation requiring hospital admission: respiratory specialist follow-up should continue for at least 12 months after admission NICE CKS.
- Features of both asthma and COPD where treatment priorities are uncertain NICE CKS.
- Asthma with food allergy and/or a history of anaphylaxis, because this combination carries increased risk of asthma-related death NICE CKS.
Additional paediatric referral indications
- Under 5 years: inability to perform objective tests and symptoms not responding to initial treatment NICE CKS.
- Preschool wheeze: refer to a specialist respiratory paediatrician after one hospital admission or two or more emergency department admissions within 12 months with wheeze NICE CKS.
- Significant treatment adverse effects, such as faltering growth NICE CKS.
Key References
- NICE CKS: Asthma
- NICE CKS: Chronic obstructive pulmonary disease
- SmPC: WockAIR 160 micrograms/4.5 micrograms inhalation powder
- SmPC: DuoResp Spiromax 160 micrograms / 4.5 micrograms inhalation powder
- SmPC: Fostair NEXThaler 100/6
- SmPC: Sereflo Ciphaler 50 microgram / 250 microgram per dose inhalation powder, predispensed